Pandemics, avian influenza A (H5N1), and a strategy for pharmacists

Pharmacotherapy
Stephen M Ford, John D Grabenstein

Abstract

Epidemics of influenza occur annually and account for more morbidity in the developed world than all other respiratory diseases combined. On average, 36,000 Americans die from influenza or its complications each year. Pandemics occur when influenza viruses undergo either antigenic drift or antigenic shift that results in a new viral strain that infects humans, when they are capable of sustained transmission from person-to-person, and when they are introduced in populations with little or no preexisting immunity. The influenza pandemic of 1918 caused an estimated 20-40 million deaths worldwide. An avian influenza A (H5N1) virus, currently circulating in Asia, has pandemic potential. However, no evidence currently exists that a pandemic is occurring. Pharmacists are uniquely positioned to initiate nearterm practice changes that may positively impact both seasonal and potential pandemic morbidity and mortality. Pharmacists must be immunization advocates and provide pharmaceutical care that includes evaluation of immunization status. Increasing immunization to prevent invasive pneumococcal disease, as well as seasonal influenza immunization, is encouraged. A pandemic vaccine represents the most effective strategy to mitigate the ef...Continue Reading

References

Jul 15, 1999·JAMA : the Journal of the American Medical Association·A S MontoA Crisp
Oct 28, 1999·The New England Journal of Medicine·F G HaydenR G Mills
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L KaiserF G Hayden
Nov 4, 2000·The New England Journal of Medicine·F G HaydenUNKNOWN Zanamivir Family Study Group
Nov 23, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·C LeeA McGeer
Jan 9, 2001·Clinical Microbiology Reviews·T Horimoto, Y Kawaoka
Feb 15, 2001·JAMA : the Journal of the American Medical Association·R WelliverUNKNOWN Oseltamivir Post Exposure Prophylaxis Investigator Group
Feb 27, 2001·The Pediatric Infectious Disease Journal·R J WhitleyP Ward
Sep 14, 2001·Journal of the American Geriatrics Society·P H PetersP Ward
May 2, 2002·Journal of the American Geriatrics Society·Susan K BowlesUNKNOWN Oseltamivir Compassionate Use Program Group
Aug 7, 2002·Vaccine·Erich HoffmannRobert G Webster
Oct 29, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Z HirjiJ Conly
Nov 26, 2002·The Journal of Infectious Diseases·Arnold S MontoCaron Kerr
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·F Y AokiUNKNOWN IMPACT Study Group
Jan 9, 2003·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Jun 13, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David S Fedson
Jul 30, 2003·Archives of Internal Medicine·Laurent KaiserFrederick Hayden
Feb 6, 2004·Expert Review of Vaccines·H Grant Stiver
Feb 27, 2004·The New England Journal of Medicine·Tinh Hien TranUNKNOWN World Health Organization International Avian Influenza Investigative Team
May 25, 2004·Expert Opinion on Biological Therapy·J M Audsley, G A Tannock
May 27, 2004·Vaccine·Terrence E SteyerArch G Mainous
Jun 12, 2004·Journal of the American Pharmacists Association : JAPhA·Mary S Hayney
Aug 4, 2004·The Lancet Infectious Diseases·Iain StephensonJacqueline M Katz
Aug 25, 2004·The Journal of Pharmacy and Pharmacology·Chun-Lei Li, Ying-Jie Deng
Sep 21, 2004·Nature Reviews. Microbiology·John M Wood, James S Robertson
Nov 5, 2004·The New England Journal of Medicine·Robert B BelsheGary Dubin
Nov 5, 2004·The New England Journal of Medicine·Richard T KenneyGregory M Glenn
Jan 25, 2005·The Pediatric Infectious Disease Journal·Stanley A Plotkin
Jan 26, 2005·The New England Journal of Medicine·Kumnuan UngchusakSupamit Chunsutthiwat
Mar 10, 2005·Vaccine·Gregory A PolandRobert M Jacobson
Mar 11, 2005·The New England Journal of Medicine·Thomas H Weller
Apr 19, 2005·Expert Opinion on Biological Therapy·G A Marsh, G A Tannock
Sep 30, 2005·The New England Journal of Medicine·Anne Moscona
Sep 30, 2005·The New England Journal of Medicine·John H BeigelUNKNOWN Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5
Dec 24, 2005·The New England Journal of Medicine·Anne Moscona
Dec 24, 2005·The New England Journal of Medicine·Menno D de JongJeremy Farrar
Feb 24, 2006·Emerging Infectious Diseases·Peter Palese

❮ Previous
Next ❯

Citations

Sep 25, 2008·Journal of Biomolecular Screening·William E SeversonColleen B Jonsson
Jun 3, 2010·The Annals of Pharmacotherapy·Carissa E MancusoSherilyn J Vanosdol
May 28, 2013·American Journal of Physiology. Lung Cellular and Molecular Physiology·Diana L Noah, James W Noah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

The New England Journal of Medicine
Ravindra K Gupta, Jonathan S Nguyen-Van-Tam
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Jennifer K Thomas, Jennifer Noppenberger
The New England Journal of Medicine
Menno D de JongJeremy Farrar
© 2021 Meta ULC. All rights reserved